Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3013247	li-/s-alb	mg/g (mg/g)	938	1002	0.00%
3013247	li-/s-alb	— (—)	57	58	100.00%	Distribution not available
3013247	s-alb	mg/g (mg/g)	6	6	0.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Other demyelinating diseases of the central nervous system

133

76.93

247.44

1.0

1.1

5.05

5.66

mg/g

0.50

124

Disturbances of skin sensation

225

214

10.68

206.15

1.1

1.0

5.72

6.84

mg/g

1.25

212

202

Neurological diseases

346

179

9.78

201.76

1.1

1.0

7.00

6.27

mg/g

0.43

331

172

Visual disturbances

221

349

6.38

132.94

1.1

7.26

6.74

mg/g

0.19

210

332

Visual disturbances and blindness

226

369

6.17

131.50

1.1

7.24

6.78

mg/g

0.17

214

352

Autoimmune diseases related-to ILD

315

632

4.40

120.34

1.0

1.1

5.82

7.60

mg/g

3.17

292

608

Symptoms and signs involving the skin and subcutaneous tissue

267

553

4.83

118.86

1.1

5.97

7.02

mg/g

1.69

253

523

Optic neuritis

29.17

116.28

1.1

1.0

4.74

5.59

mg/g

0.93

Symptoms and signs involving the nervous and musculoskeletal systems

223

446

5.03

104.23

1.1

6.90

6.86

mg/g

0.03

207

426

Autoimmune diseases excluding thyroid diseases

355

515

3.84

96.38

1.1

6.78

7.16

mg/g

0.26

331

495

Autoimmune diseases excluding thyroid diseases, strict definition

346

506

3.82

93.61

1.1

6.78

7.22

mg/g

0.31

322

486

Abnormal findings on diagnostic imaging of central nervous system

26.12

90.51

1.1

1.0

5.60

5.78

mg/g

0.10

ILD medications: immunosuppressive drugs

222

503

4.25

83.56

1.1

6.67

7.37

mg/g

0.53

210

479

Headache

221

485

3.82

69.26

1.1

1.0

7.00

6.39

mg/g

0.25

208

463

Other neurological diseases

197

378

4.21

69.23

1.1

8.62

7.32

mg/g

0.50

187

358

Subjective visual disturbances

103

146

7.11

68.79

1.0

1.1

7.39

7.19

mg/g

0.03

141

ILD medications

327

591

3.05

63.55

1.1

6.36

7.12

mg/g

0.77

306

566

Autoimmune diseases

312

517

3.09

60.49

1.1

6.52

7.15

mg/g

0.48

294

497

Used for control exclusion in common control thyroid runs

293

490

3.04

55.24

1.1

6.58

7.23

mg/g

0.47

275

471

General symptoms and signs

301

524

2.89

51.95

1.1

1.0

7.25

6.67

mg/g

0.30

283

501

L04AA Selective immunosuppressants

176

5.50

49.78

1.1

1.0

5.42

7.16

mg/g

1.88

165

Symptoms and signs involving cognition, perception, emotional state and behaviour

254

614

2.91

49.55

1.1

6.55

7.03

mg/g

0.56

237

584

Cerebrovascular diseases (FINNGEN)

117

180

4.67

44.91

1.1

7.42

6.98

mg/g

0.26

112

167

Malaise and fatigue

120

245

4.09

41.48

1.1

1.0

7.30

7.18

mg/g

0.06

112

234

Other symptoms and signs involving the nervous and musculoskeletal systems

123

322

3.84

41.04

1.1

5.74

6.34

mg/g

0.67

114

307

Cerebrovascular diseases

149

298

3.59

41.00

1.1

7.52

8.30

mg/g

0.58

141

279

Pain in limb

214

564

2.75

38.30

1.1

7.08

6.40

mg/g

0.55

203

543

Other symptoms and signs involving cognitive functions and awareness

201

4.45

37.94

1.1

7.93

7.71

mg/g

0.10

192

Stroke, excluding SAH

112

202

4.13

37.71

1.1

7.67

8.72

mg/g

0.70

106

189

Stroke, including SAH

119

225

3.92

37.44

1.1

7.80

8.41

mg/g

0.37

113

211

Dizziness and giddiness

170

460

3.01

36.83

1.1

6.03

7.15

mg/g

1.64

157

437

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

133

368

3.36

35.78

1.1

6.79

8.02

mg/g

1.21

127

346

Ischaemic Stroke, excluding all haemorrhages

101

179

4.28

35.77

1.1

7.51

9.06

mg/g

1.11

169

STROKE

139

288

3.36

34.38

1.1

7.80

7.57

mg/g

0.13

130

274

Other soft tissue disorders, not elsewhere classified

240

593

2.51

34.37

1.1

6.58

6.78

mg/g

0.12

225

569

Second line medication for Crohn's disease

157

542

2.91

33.72

1.1

7.08

6.74

mg/g

0.25

147

511

L04AX Other immunosuppressants

153

526

2.92

33.12

1.1

7.10

6.78

mg/g

0.23

143

497

Diseases of the eye and adnexa

224

432

2.60

32.41

1.0

1.1

5.65

6.92

mg/g

2.30

213

411

Migraine

156

459

2.90

32.16

1.1

1.0

5.37

6.15

mg/g

1.12

144

438

Episodal and paroxysmal disorders

269

590

2.34

31.65

1.1

5.91

7.19

mg/g

1.68

252

562

ILD medications: prednisolone, methylprednisolone, prednisone

240

576

2.36

29.61

1.1

6.73

7.19

mg/g

0.36

223

551

Papilloedema, unspecified

20.52

28.50

1.1

1.0

17.18

5.58

mg/g

0.65

Mood disorders, excluding more controls

213

536

2.42

28.46

1.1

6.20

7.24

mg/g

1.52

201

513

Depression

227

695

2.25

26.71

1.1

6.07

7.23

mg/g

1.55

217

660

Anxiety disorders, excluding more controls

192

523

2.44

26.67

1.1

6.16

7.10

mg/g

1.27

178

500

Mood [affective] disorders

235

705

2.20

25.76

1.1

6.09

7.36

mg/g

1.78

223

670

Mood disorders

235

705

2.19

25.67

1.1

6.09

7.36

mg/g

1.78

223

670

Anxiety disorders

220

701

2.23

25.43

1.1

6.07

7.21

mg/g

1.53

205

671

Other spirochaetal diseases

154

4.24

25.02

1.0

1.1

9.50

6.80

mg/g

1.41

143

Neurotic, stress-related and somatoform disorders

217

702

2.20

24.41

1.1

6.07

7.18

mg/g

1.43

202

672

Lyme disease

153

4.20

24.36

1.0

1.1

9.52

6.83

mg/g

1.37

142

Disorders of ocular muscles, binocular movement, accommodation and refraction

133

508

2.60

23.31

1.1

7.14

6.28

mg/g

0.22

126

483

Small fibre neuropathy

17.61

22.96

1.0

8.89

7.17

mg/g

0.45

Migraine with aura

234

3.43

22.87

1.1

1.0

5.26

5.80

mg/g

0.63

226

Other headache syndromes

107

373

2.88

22.78

1.0

7.20

6.58

mg/g

0.38

353

Pain in joint

133

329

2.68

22.42

1.1

6.87

6.77

mg/g

0.05

124

313

Recurrent or chronic depression

115

296

2.81

21.72

1.1

5.54

6.77

mg/g

1.81

109

282

Condition for Implicit Sepsis (Organ dysfunction codes)

169

531

2.32

21.59

1.1

7.07

6.93

mg/g

0.10

158

506

Anxiety (asthma-related co-morbidities)

164

558

2.32

21.49

1.1

5.70

7.17

mg/g

1.83

158

526

Psychiatric diseases

227

536

2.12

21.42

1.1

6.18

7.20

mg/g

1.40

213

510

Extrapyramidal and movement disorders

197

3.56

21.24

1.2

1.0

6.02

7.73

mg/g

1.39

185

Any reimbursement code in KELA

169

357

2.38

20.64

1.1

6.52

5.90

mg/g

0.51

164

341

Sixth [abducent] nerve palsy

15.22

20.23

1.1

1.0

5.44

6.65

mg/g

0.57

Any mental disorder

224

546

2.06

19.56

1.1

6.25

7.19

mg/g

1.18

210

521

All anxiety disorders

168

616

2.20

19.53

1.1

5.67

6.91

mg/g

1.55

161

587

Guillain-Barre syndrome

35.69

19.03

1.3

1.0

19.69

5.98

mg/g

—

Syncope and collapse

224

3.13

19.02

1.1

1.0

6.68

7.34

mg/g

0.40

216

Epilepsy

243

3.13

18.80

1.1

1.0

6.64

6.88

mg/g

0.12

235

Meningitis

8.15

18.77

1.1

1.0

12.14

8.11

mg/g

0.94

First line medication for Crohn's disease

239

669

1.95

18.56

1.1

7.61

6.49

mg/g

0.57

225

639

Hard cardiovascular diseases

129

337

2.46

18.30

1.1

8.03

7.96

mg/g

0.03

122

319

Depression or dysthymia

144

341

2.37

18.11

1.0

1.1

6.79

7.20

mg/g

0.27

137

326

Special screening examination for infectious and parasitic diseases

234

2.89

18.02

1.1

6.44

5.58

mg/g

0.91

223

Other anxiety disorders

130

498

2.32

17.55

1.1

5.69

6.52

mg/g

0.70

121

473

Tramadol

156

463

2.17

16.74

1.1

7.38

7.04

mg/g

0.22

145

437

Opioids

214

579

1.94

16.34

1.1

6.31

6.91

mg/g

0.54

203

548

Nerve, nerve root and plexus disorders

201

650

1.95

16.11

1.1

7.17

6.90

mg/g

0.17

184

622

Soft tissue disorders

223

610

1.90

15.96

1.1

6.24

6.83

mg/g

0.51

207

585

Other antidepressants

205

550

1.95

15.74

1.1

6.42

7.32

mg/g

0.87

194

521

Migraine without aura

218

3.04

15.62

1.1

1.0

5.73

5.65

mg/g

0.04

212

Examination and observation for other reasons

125

331

2.30

15.21

1.1

6.71

6.08

mg/g

0.54

120

318

Inflammatory bowel disease treatment related agents

231

718

1.83

15.09

1.1

6.66

7.03

mg/g

0.32

216

684

Other dorsopathies, not elsewhere classified

215

607

1.87

14.78

1.1

6.71

6.76

mg/g

0.04

202

577

Pain (limb, back, neck, head abdominally)

145

339

2.15

14.25

1.1

6.68

6.65

mg/g

0.02

139

322

Codeine

193

563

1.89

13.78

1.1

6.48

6.91

mg/g

0.33

183

534

Other diseases of urinary system

198

598

1.87

13.75

1.1

6.68

6.50

mg/g

0.12

182

575

Medical observation and evaluation for suspected diseases and conditions

138

336

2.11

13.09

1.1

6.54

6.10

mg/g

0.28

131

323

Myalgia

178

3.04

12.89

1.0

5.11

6.16

mg/g

1.45

172

Implicit Sepsis

122

451

2.11

12.83

1.1

6.97

7.20

mg/g

0.15

114

429

Oral corticosteroids

201

675

1.80

12.83

1.1

6.79

7.13

mg/g

0.26

187

643

Cystitis

162

513

1.93

12.80

1.1

6.99

6.24

mg/g

0.58

151

492

Certain infectious and parasitic diseases

201

559

1.80

12.26

1.1

7.03

6.29

mg/g

0.56

186

535

Systemic connective tissue disorders

240

2.67

12.10

1.0

1.1

7.01

6.86

mg/g

0.06

228

Symptoms and signs involving speech and voice

213

2.78

12.00

1.0

6.90

7.26

mg/g

0.17

200

Other diseases of spinal cord

12.12

11.75

1.0

5.60

6.26

mg/g

—

Disorders of lacrimal system

310

2.42

11.62

1.1

1.0

6.45

6.74

mg/g

0.16

291

Dorsalgia

197

603

1.77

11.60

1.1

6.53

6.73

mg/g

0.13

184

573

Exposure to unspecified factor

182

810

1.75

11.03

1.1

7.28

6.88

mg/g

0.24

174

768

Dysphagia

137

3.15

10.92

1.1

1.0

9.24

7.72

mg/g

0.38

132

Symptoms and signs involving the circulatory and respiratory systems

215

633

1.70

10.92

1.1

6.88

mg/g

0.00

203

603

Persons encountering health services in other circumstances, wide

220

678

1.69

10.83

1.1

7.53

7.05

mg/g

0.30

210

642

Use of dimethyl fumarate

19.57

10.36

1.0

5.45

5.57

mg/g

—

Codeine or tramadol medication

210

695

1.68

10.30

1.1

6.48

7.10

mg/g

0.61

200

658

Paraplegia, diplegia of upper limbs

19.07

10.29

1.2

1.0

13.04

6.72

mg/g

—

Dorsopathies

202

617

1.67

9.69

1.1

6.69

6.75

mg/g

0.04

189

587

Migraine, single triptan purchase ok & required. ICD-code if available is included

165

645

1.73

9.60

1.1

5.99

6.88

mg/g

0.89

160

607

Triptan medication for migraine, single purchase ok

165

645

1.73

9.60

1.1

5.99

6.88

mg/g

0.89

160

607

SLE (Finngen)

10.07

9.55

1.0

9.20

6.68

mg/g

0.42

Cerebral arteritis

+∞

9.53

2.0

0.0

10.23

—

mg/g

—

Symptoms and signs involving the urinary system

120

491

1.89

9.50

1.1

8.43

7.05

mg/g

0.94

112

465

Persons encountering health services for other counselling and medical advice, not elsewhere classified

197

677

1.66

9.46

1.1

7.27

7.05

mg/g

0.12

188

641

Nausea and vomiting

199

2.58

9.20

1.1

10.27

6.36

mg/g

0.42

192

Other meningitis

9.32

8.99

1.2

1.0

8.05

5.53

mg/g

0.41

Other systemic involvement of connective tissue (FG)

154

2.78

8.85

1.0

1.1

6.44

6.39

mg/g

0.02

148

Selective serotonin reuptake inhibitors

177

555

1.68

8.77

1.1

6.92

7.30

mg/g

0.23

170

526

Other special examinations and investigations of persons without complaint or reported diagnosis

123

336

1.85

8.40

1.0

1.1

6.87

6.10

mg/g

0.55

115

323

Other systemic involvement of connective tissue

173

2.61

8.23

1.0

1.1

6.40

6.71

mg/g

0.12

166

Cardiovascular diseases

160

516

1.69

8.21

1.1

5.99

6.34

mg/g

0.23

155

490

Use of fingolimod

17.69

8.13

1.1

1.0

4.53

6.36

mg/g

—

Disorders of eyelid, lacrimal system and orbit

132

596

1.74

8.07

1.1

7.00

6.88

mg/g

0.08

126

563

Myasthenia gravis

22.38

8.04

1.0

6.60

6.52

mg/g

—

Other disorders of urethra and urinary system

113

470

1.80

7.77

1.1

1.0

6.77

6.34

mg/g

0.23

102

451

Benign intracranial hypertension

15.46

7.76

1.0

24.99

4.99

mg/g

—

Other reaction to severe stress, and adjustment disorders

431

1.95

7.74

1.1

5.89

6.01

mg/g

0.07

410

Asthma, excluding more controls

143

446

1.71

7.65

1.1

7.06

6.72

mg/g

0.20

133

428

GASTRO-related operations

167

511

1.64

7.56

1.1

6.28

6.60

mg/g

0.21

156

490

Any gastric operation

167

511

1.64

7.56

1.1

6.28

6.60

mg/g

0.21

156

490

Asthma

143

453

1.69

7.42

1.1

7.06

6.72

mg/g

0.20

133

435

Bacterial meningitis

5.96

7.38

1.0

15.17

6.42

mg/g

1.72

Low back pain

125

567

1.70

7.09

1.1

6.17

6.35

mg/g

0.15

119

540

Pain in throat and chest

153

578

1.62

6.92

1.0

1.1

7.52

6.96

mg/g

0.15

147

553

Other specific joint derangements/joint disorders

148

614

1.62

6.80

1.1

6.88

6.96

mg/g

0.04

138

588

Diseases of inner ear

363

1.94

6.60

1.1

5.75

7.50

mg/g

2.82

342

Asthma (mode)

137

457

1.65

6.51

1.1

7.04

6.72

mg/g

0.18

127

439

Neuralgia and neuritis, unspecified

4.85

6.45

1.2

1.0

12.35

7.59

mg/g

0.39

Systemic lupus erythematosus

5.83

6.11

1.0

1.1

9.20

6.05

mg/g

0.57

COPD differential diagnosis

146

457

1.60

6.10

1.1

6.38

6.72

mg/g

0.27

137

439

ILD differential diagnosis

146

457

1.60

6.10

1.1

6.38

6.72

mg/g

0.27

137

439

Cardiovascular diseases (excluding rheumatic etc)

151

556

1.57

6.01

1.1

6.27

6.26

mg/g

0.01

143

529

Disorders of optic nerve, not elsewhere classified

15.16

5.91

1.3

1.0

7.86

7.19

mg/g

—

Abnormalities of breathing

161

625

1.53

5.81

1.0

1.1

6.65

6.87

mg/g

0.16

151

595

Lower back pain or/and sciatica

167

768

1.51

5.80

1.1

6.55

6.82

mg/g

0.24

159

729

Viral hepatitis, IBD co-morbidity

11.15

5.79

1.1

1.0

4.55

4.65

mg/g

—

Excluding asthma or asthma-COPD overlap

144

456

1.58

5.77

1.1

6.36

6.72

mg/g

0.29

135

438

Acute upper respiratory infections

170

710

1.50

5.66

1.0

1.1

6.48

7.10

mg/g

0.46

154

679

Follow-up examination after treatment for conditions other than malignant neoplasms

280

1.83

5.57

1.0

6.30

5.96

mg/g

0.19

269

Chronic sinusitis

416

1.80

5.56

1.1

6.99

6.71

mg/g

0.14

389

Other external causes of accidental injury

152

493

1.55

5.52

1.1

6.98

6.54

mg/g

0.25

144

465

Diseases of the musculoskeletal system and connective tissue

113

343

1.65

5.42

1.1

6.21

6.67

mg/g

0.22

108

331

SLE, ICD10

5.59

5.32

1.0

8.33

6.14

mg/g

—

SLE, strict definition

5.59

5.32

1.0

8.32

6.14

mg/g

—

Symptoms and signs concerning food and fluid intake

3.55

5.31

1.1

1.0

8.13

7.90

mg/g

0.03

Hypothyroidism, strict autoimmune

376

1.67

5.09

1.1

6.03

6.61

mg/g

0.46

361

Other pulmonary diagnosis

140

456

1.54

5.04

1.1

6.24

6.72

mg/g

0.40

131

438

Exposure to other specified factors

128

786

1.53

5.01

1.1

6.53

7.06

mg/g

0.41

123

742

Dyspnoea

131

656

1.53

5.00

1.0

1.1

5.89

6.98

mg/g

2.02

122

622

Disorders of lipoprotein metabolism and other lipidaemias

100

382

1.65

5.00

1.0

1.1

8.71

7.73

mg/g

0.58

362

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

151

729

1.49

4.96

1.1

7.32

6.74

mg/g

0.38

143

691

Care involving use of rehabilitation procedures

567

1.63

4.95

1.1

7.10

6.88

mg/g

0.10

537

Intestinal infectious diseases

154

814

1.47

4.93

1.1

6.55

7.06

mg/g

0.45

146

772

Parasetamol

153

522

1.50

4.89

1.1

6.67

mg/g

0.00

146

500

Injuries to the wrist and hand

163

814

1.45

4.80

1.1

6.74

6.96

mg/g

0.14

155

772

Bacterial Sepsis

196

2.04

4.78

1.0

1.1

10.33

8.25

mg/g

0.82

187

Nephropathy related operations

2.88

4.75

1.2

1.0

11.92

9.53

mg/g

0.46

Other diseases of hard tissues of teeth

108

510

1.58

4.75

1.1

6.10

7.25

mg/g

1.32

100

494

Triptan medication for migraine, min. 3 purchases

116

591

1.55

4.74

1.1

6.15

5.84

mg/g

0.20

110

557

Other intervertebral disc disorders

124

493

1.54

4.71

1.1

7.70

6.61

mg/g

0.72

117

467

Asthma (only as main-diagnosis)

117

453

1.56

4.68

1.1

6.29

6.72

mg/g

0.38

110

435

Accidents

147

493

1.49

4.66

1.1

7.02

6.54

mg/g

0.27

139

465

Infections with a predominantly sexual mode of transmission

410

1.73

4.66

1.2

1.0

6.27

5.64

mg/g

0.42

387

Acute sinusitis

574

1.59

4.63

1.0

1.1

6.29

6.79

mg/g

0.34

551

All influenza

198

2.07

4.63

1.1

8.10

6.88

mg/g

0.44

189

Dystonia

4.16

4.62

1.2

1.0

5.15

6.00

mg/g

0.56

Diabetes insipidus

14.26

4.59

1.0

5.24

6.19

mg/g

—

Cauda equina syndrome

14.19

4.59

1.0

9.93

6.83

mg/g

—

Lumbar disc prolapse

469

1.61

4.59

1.1

8.16

6.73

mg/g

0.77

443

Diseases of the ear and mastoid process

202

731

1.40

4.57

1.1

6.23

7.17

mg/g

1.05

193

693

Coxibs

129

2.02

4.54

1.0

1.1

6.68

5.84

mg/g

0.44

123

Dialysis, with operation codes

2.81

4.54

1.2

1.0

11.74

9.60

mg/g

0.40

Dissociative [conversion] disorders

3.85

4.54

1.0

4.81

5.53

mg/g

0.52

Other disorders of optic disc

10.15

4.53

1.0

5.98

5.44

mg/g

—

Asthma (only as main-diagnosis), excluding more controls

116

446

1.55

4.53

1.1

6.31

6.72

mg/g

0.35

109

428

Metabolic disorders

139

583

1.48

4.45

1.1

7.52

6.86

mg/g

0.55

131

554

Symptoms and signs involving the digestive system and abdomen

167

583

1.44

4.37

1.1

7.92

6.83

mg/g

0.36

156

558

Persons encountering health services for examination and investigation

106

336

1.58

4.37

1.1

7.04

6.10

mg/g

0.65

323

Pure hypercholesterolaemia

319

1.66

4.22

1.1

8.62

8.18

mg/g

0.18

301

Acute bronchitis

342

1.75

4.17

1.1

5.82

6.48

mg/g

0.85

328

Asthma-related infections

578

1.57

4.13

1.1

6.75

6.65

mg/g

0.05

546

Asthma, hospital admission 2, infections

578

1.57

4.13

1.1

6.75

6.65

mg/g

0.05

546

Immunodeficiency with predominantly antibody defects

6.48

3.99

1.3

1.0

6.23

5.65

mg/g

—

Sciatica+with lumbago

423

1.64

3.95

1.1

7.26

6.73

mg/g

0.26

398

Other specified/unspecified inflammatory spondylopathies

3.65

3.92

1.1

1.0

7.55

6.95

mg/g

0.07

Diarrhoea and gastroenteritis of presumed infectious origin

116

717

1.47

3.87

1.1

6.59

6.74

mg/g

0.09

109

680

Persistent mood disorders

145

2.14

3.85

1.0

1.1

5.79

7.54

mg/g

1.55

137

469

1.61

3.85

1.1

6.75

6.42

mg/g

0.15

444

Erosion of teeth

8.83

3.78

1.1

1.0

10.11

2.98

mg/g

—

Somnolence

12.13

3.77

1.2

1.0

9.82

6.21

mg/g

—

Voice disturbances

180

2.00

3.77

1.0

6.65

7.07

mg/g

0.17

170

Obesity, other/unspecified

354

1.70

3.74

1.1

6.45

6.36

mg/g

0.05

331

Conjunctivitis

129

787

1.43

3.70

1.0

1.1

6.19

6.79

mg/g

0.51

124

743

Asthma (diagnoses ohter than nonallergic)

135

816

1.42

3.67

1.1

6.44

6.94

mg/g

0.38

126

775

Benign neoplasms

168

683

1.37

3.59

1.1

6.91

6.67

mg/g

0.15

158

651

Autonomic disorders

7.83

3.56

1.1

1.0

10.46

6.54

mg/g

—

Asthma, unspecified (mode), excluding more controls

383

1.58

3.52

1.0

1.1

6.64

6.83

mg/g

0.10

365

Other congenital malformations of circulatory system

5.34

3.51

1.1

1.0

6.34

5.71

mg/g

—

Malignant neoplasm of brain

5.32

3.51

1.1

1.0

32.35

7.84

mg/g

—

Other specified/unspecified necrotizing vasculopathies

10.10

3.50

1.3

1.0

9.16

6.14

mg/g

—

Other facial nerve disorders

6.19

3.50

1.0

4.77

7.12

mg/g

—

Asthma, unspecified (mode)

388

1.57

3.48

1.0

1.1

6.64

6.85

mg/g

0.11

370

Diseases of the respiratory system

111

377

1.48

3.44

1.0

1.1

6.84

6.45

mg/g

0.23

104

359

Other acute lower respiratory infections

487

1.55

3.43

1.1

6.81

6.86

mg/g

0.02

465

Bacterial infection, other or unspecified

306

1.68

3.42

1.1

1.0

10.50

7.15

mg/g

1.20

292

Behavioural disorders

5.04

3.37

1.1

1.0

28.10

4.70

mg/g

—

Statin medication

118

459

1.44

3.34

1.1

8.25

6.86

mg/g

1.07

108

438

Benign neoplasms

145

591

1.39

3.34

1.1

6.65

5.93

mg/g

0.67

138

564

External causes of morbidity and mortality

120

418

1.44

3.29

1.1

6.57

6.55

mg/g

0.01

114

396

Myeloid leukaemia

8.62

3.26

1.3

1.0

8.40

6.78

mg/g

—

Cluster headache, strict

4.76

3.24

1.0

7.59

8.95

mg/g

—

Abdominal and pelvic pain

158

582

1.37

3.22

1.1

6.36

6.83

mg/g

0.43

151

557

Fall on same level

187

790

1.32

3.18

1.1

7.44

6.78

mg/g

0.48

176

751

Dermatitis and eczema

167

820

1.34

3.12

1.1

6.87

7.00

mg/g

0.06

160

777

Conduct disorder

4.53

3.12

1.1

28.10

6.66

mg/g

—

Cluster headache, wide

4.52

3.11

1.0

7.59

8.67

mg/g

—

Shoulder lesions

405

1.47

3.08

1.0

1.1

7.96

7.12

mg/g

0.44

391

Disorders of conjunctiva

131

798

1.38

3.07

1.0

1.1

6.27

6.79

mg/g

0.41

126

753

Other specified and unspecified strabismus

7.59

3.06

1.2

1.0

4.18

10.07

mg/g

—

Open wound of lower leg

2.23

3.05

1.0

9.09

7.82

mg/g

0.23

Other diseases of upper respiratory tract

167

651

1.34

3.04

1.1

6.71

7.07

mg/g

0.24

160

616

Transport accidents

431

1.52

3.00

1.1

5.98

6.54

mg/g

0.30

406

Neoplasms

148

584

1.36

3.00

1.1

7.92

5.92

mg/g

0.72

141

558

Use of hypnotics and sedatives

158

682

1.34

2.98

1.1

7.08

6.93

mg/g

0.11

147

648

Bronchitis

160

788

1.33

2.96

1.1

6.22

7.09

mg/g

0.84

143

755

Constipation

112

572

1.40

2.91

1.1

7.34

6.89

mg/g

0.25

100

548

Other specified/unspecified hearing loss

2.93

2.85

1.1

1.0

5.64

10.08

mg/g

1.92

Finngen Rheumatological endpoints

160

687

1.33

2.85

1.0

1.1

6.66

6.95

mg/g

0.18

147

657

Sleep disorders (combined)

145

708

1.34

2.85

1.1

6.37

7.34

mg/g

1.09

137

673

Asthma, including avohilmo

180

804

1.30

2.79

1.1

6.74

7.03

mg/g

0.19

167

766

Persons encountering health services for specific procedures and health care

166

783

1.31

2.79

1.1

7.01

6.91

mg/g

0.06

158

742

Injuries to the knee and lower leg

180

794

1.30

2.74

1.1

7.70

6.78

mg/g

0.73

173

751

Acute upper respiratory infections of multiple and unspecified sites

120

658

1.37

2.72

1.0

1.1

6.20

6.87

mg/g

0.52

109

627

Gingivitis and periodontal diseases

134

510

1.36

2.71

1.0

1.1

6.29

7.30

mg/g

1.04

120

494

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

134

623

1.35

2.70

1.1

7.12

7.00

mg/g

0.07

124

596

134

623

1.35

2.70

1.1

7.12

7.00

mg/g

0.07

124

596

Nystagmus and other irregular eye movements

6.05

2.70

1.0

5.67

5.10

mg/g

—

Human immunodeficiency virus [HIV] disease resulting in other conditions

6.04

2.70

1.0

11.41

6.37

mg/g

—

Falls/tendency to fall

182

703

1.30

2.69

1.1

6.68

6.58

mg/g

0.05

170

669

Other joint disorders

155

624

1.32

2.69

1.0

1.1

6.46

6.99

mg/g

0.36

146

598

Endocrine, nutritional and metabolic diseases

152

584

1.33

2.64

1.1

7.35

6.42

mg/g

0.67

143

553

Diseases of oral cavity, salivary glands and jaws

135

515

1.35

2.60

1.1

6.14

7.25

mg/g

1.26

121

499

Tobacco use

2.91

2.58

1.3

1.0

5.07

7.61

mg/g

1.32

Disorders of choroid and retina

449

1.43

2.57

1.1

7.58

7.71

mg/g

0.07

424

Other and unspecified trigeminal disorders

7.19

2.55

1.4

1.0

6.77

5.76

mg/g

—

Human immunodeficiency virus [HIV] disease

5.49

2.55

1.0

11.41

6.16

mg/g

—

Hypertensive diseases (excluding secondary)

372

1.42

2.51

1.1

8.51

6.42

mg/g

1.46

352

Arthropathies

161

629

1.30

2.51

1.0

1.1

6.71

6.96

mg/g

0.14

153

603

Cardiac arrhythmias

102

487

1.39

2.48

1.0

1.1

6.50

6.29

mg/g

0.12

462

Other and unspecified iridocyclitis

3.47

2.48

1.0

7.14

6.26

mg/g

—

Obsessive-compulsive disorder

2.33

2.48

1.0

5.79

6.18

mg/g

0.15

Other functional intestinal disorders

340

1.54

2.44

1.1

1.0

8.05

6.76

mg/g

0.49

324

Gastrointestinal diseases

118

436

1.36

2.42

1.1

5.80

6.76

mg/g

0.76

112

417

Disturbances of smell and taste

4.13

2.36

1.1

4.92

6.36

mg/g

—

Post-traumatic stress disorder

2.15

2.34

1.1

1.0

5.23

5.64

mg/g

0.22

Influenza and pneumonia

159

816

1.28

2.32

1.1

7.29

6.81

mg/g

0.36

147

777

Asthma, hospital admissions , main diagnosis only

122

830

1.32

2.28

1.1

6.42

6.96

mg/g

0.46

115

788

Perineal laceration during delivery

245

0.44

2.27

1.0

1.1

5.50

4.57

mg/g

0.68

234

Systemic lupus erythematosus, unspecified

3.91

2.25

1.0

5.89

6.14

mg/g

—

Other salmonella infections

3.90

2.25

1.1

1.0

6.35

6.70

mg/g

—

Hypertension, essential

113

481

1.34

2.23

1.1

8.36

7.04

mg/g

0.98

104

453

Congenital malformations, deformations and chromosomal abnormalities

101

719

1.35

2.22

1.0

1.1

7.35

6.51

mg/g

0.48

681

Pregnancy, childbirth and the puerperium

194

0.51

2.22

1.1

1.0

5.41

5.33

mg/g

0.04

185

Peroneal tendinitis

5.59

2.21

1.0

1.1

5.19

6.41

mg/g

—

Melanocytic naevi

256

1.60

2.20

1.1

7.27

6.37

mg/g

0.46

245

Delivery, wide proxy

231

0.55

2.19

1.1

5.65

5.49

mg/g

0.08

220

Vertical strabismus

3.35

2.18

1.0

6.36

7.27

mg/g

—

Complications of medical and surgical care

643

1.36

2.15

1.1

6.34

7.01

mg/g

0.59

605

Soft tissue disorders related to use, overuse and pressure

151

1.79

2.15

1.1

1.0

5.70

7.19

mg/g

1.30

144

Osteopathies and chondropathies

451

1.43

2.15

1.1

6.72

7.07

mg/g

0.17

430

Sequelae of injuries, of poisoning and of other consequences of external causes

204

1.67

2.13

1.0

1.1

6.15

7.12

mg/g

0.77

193

COPD/asthma related infections

158

623

1.27

2.08

1.0

1.1

6.14

7.00

mg/g

0.79

144

596

COPD/asthma/ILD related infections

158

623

1.27

2.08

1.0

1.1

6.14

7.00

mg/g

0.79

144

596

3.99

2.03

1.0

8.09

6.04

mg/g

—

Melanocytic naevi

264

1.55

1.96

1.1

1.0

7.27

6.50

mg/g

0.38

251

Other heart diseases

395

1.37

1.96

1.0

1.1

6.64

6.38

mg/g

0.13

377

Injuries to the ankle and foot

112

786

1.30

1.95

1.0

1.1

7.85

6.48

mg/g

0.90

105

744

Torticollis

4.57

1.94

1.4

1.0

10.92

5.21

mg/g

—

Other and unspecified diseases of blood and blood-forming organs

4.56

1.94

1.0

7.24

6.77

mg/g

—

Amblyopia ex anopsia

2.74

1.93

1.1

1.0

8.70

6.16

mg/g

—

Paroxysmal tachycardia

164

1.65

1.91

1.0

1.1

6.39

6.70

mg/g

0.09

155

Urolithiasis

189

1.64

1.86

1.0

1.1

8.05

7.85

mg/g

0.06

180

Myositis

3.54

1.84

1.2

1.0

7.61

6.55

mg/g

—

Adrenocortical insufficiency

3.54

1.84

1.3

1.0

22.55

6.44

mg/g

—

Other and unspecified acne

4.20

1.82

1.8

1.0

9.15

8.27

mg/g

—

Other nutritional deficiencies

717

1.31

1.81

1.0

1.1

6.05

6.55

mg/g

0.54

678

Disorders of orbit

3.05

1.80

1.3

1.0

10.13

6.24

mg/g

—

Otitis externa, unspecified

2.00

1.79

1.1

1.0

5.48

8.12

mg/g

1.54

Contact with sharp glass

2.77

1.79

1.1

1.0

4.28

6.97

mg/g

—

Reactive arthropathies, FINNGEN

2.44

1.75

1.0

1.1

11.07

7.14

mg/g

—

Cluster headache, strict, including avohilmo

2.51

1.74

1.0

7.59

7.16

mg/g

—

Autoimmune thyroiditis

3.87

1.71

1.4

1.0

4.12

6.21

mg/g

—

Rotator cuff syndrome

324

1.40

1.71

1.0

1.1

7.85

7.20

mg/g

0.34

312

Dental operations, only avohilmo

385

0.70

1.71

1.1

6.17

7.69

mg/g

1.26

370

All pneumoniae

144

803

1.24

1.68

1.1

7.56

6.94

mg/g

0.42

135

765

Alcohol abuse, main dg

126

1.75

1.67

1.3

1.0

7.46

7.64

mg/g

0.04

120

Diseases of tongue

2.80

1.65

1.1

1.0

7.38

9.19

mg/g

—

Dental caries 2

124

778

1.25

1.64

1.0

1.1

7.47

6.63

mg/g

0.19

114

739

Pneumonia, organism unspecified

120

690

1.26

1.63

1.1

7.90

6.66

mg/g

0.96

112

655

Anomalies of pupillary function

3.59

1.61

1.0

6.02

5.53

mg/g

—

Viral conjunctivitis

3.59

1.61

1.0

4.47

5.95

mg/g

—

Diffuse large B-cell lymphoma

3.58

1.61

1.0

16.11

7.75

mg/g

—

Social phobias

1.84

1.61

1.1

1.0

5.28

5.99

mg/g

0.37

Brain meningioma, excluding all cancers (controls excluding all cancers)

3.01

1.58

1.0

1.1

9.58

7.06

mg/g

—

Autoimmune hyperthyroidism

2.70

1.58

1.3

1.1

6.53

6.28

mg/g

—

Temporomandibular joint disorders, including avohilmo

523

1.34

1.58

1.0

1.1

6.23

5.74

mg/g

0.28

495

Event of undetermined intent

2.21

1.57

1.0

5.29

7.35

mg/g

0.97

Pneumonias (Asthma/COPD co-morbidities)

142

802

1.23

1.55

1.1

7.59

6.94

mg/g

0.44

133

764

158

685

1.22

1.55

1.0

1.1

6.18

7.13

mg/g

0.89

143

656

Additional codes for the location of defect, injury or illness

2.43

1.53

1.0

6.34

5.89

mg/g

—

Atopic dermatitis

657

1.27

1.53

1.1

5.77

6.39

mg/g

0.46

619

Dental caries 2 and operation codes, only avohilmo

104

508

1.27

1.53

1.1

8.03

6.29

mg/g

0.36

481

Dental operations

365

0.72

1.52

1.1

6.05

7.75

mg/g

1.43

351

Unspecified event, undetermined intent

3.35

1.52

1.0

5.79

7.61

mg/g

—

Campylobacter enteritis

3.34

1.52

1.0

9.23

6.88

mg/g

—

Chronic conjunctivitis

3.34

1.52

1.4

1.0

5.01

5.71

mg/g

—

Alcohol-induced acute pancreatitis

3.34

1.52

1.0

11.41

9.70

mg/g

—

Anankastic personality disorder

2.60

1.51

1.0

4.37

5.84

mg/g

—

Dentofacial anomalies [including malocclusion]

312

1.43

1.50

1.0

1.1

5.59

6.33

mg/g

0.74

305

Disorders of synovium and tendon

437

1.34

1.48

1.0

1.1

7.62

6.58

mg/g

0.51

418

Cluster headache, wide,, including avohilmo

2.44

1.48

1.0

7.59

7.20

mg/g

—

Abnormal blood-pressure reading, without diagnosis

2.51

1.45

1.1

1.0

6.89

9.32

mg/g

—

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

3.14

1.44

1.0

1.1

5.38

5.89

mg/g

—

Chronic Coagulation defects

3.14

1.44

1.0

6.47

6.06

mg/g

—

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

3.13

1.44

1.2

1.0

3.98

6.34

mg/g

—

Use of ropinirole

3.13

1.44

2.4

1.0

5.25

8.88

mg/g

—

Panniculitis affecting regions of neck and back

2.61

1.37

1.0

7.08

6.29

mg/g

—

Olecranon bursitis

2.61

1.36

1.2

1.0

5.75

9.90

mg/g

—

Injuries to the head

153

831

1.20

1.36

1.1

7.22

6.90

mg/g

0.20

146

787

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

2.95

1.36

1.0

1.1

4.73

6.09

mg/g

—

Burn and corrosion confined to eye and adnexa

2.95

1.36

1.0

6.33

6.31

mg/g

—

Intentional self-harm by sharp object

2.95

1.36

1.0

6.18

5.37

mg/g

—

Abscess of Bartholin gland

2.95

1.36

1.0

1.1

4.40

5.59

mg/g

—

Other sleep disorders

2.04

1.32

1.0

7.76

9.72

mg/g

0.38

LSIL lesion of the cervix uteri

136

1.62

1.32

1.0

1.1

4.87

4.80

mg/g

0.04

131

Agoraphobia

2.51

1.30

1.0

4.21

5.42

mg/g

—

Hypertension

112

514

1.23

1.30

1.1

8.64

6.93

mg/g

1.35

103

485

Other specified and unspecified retinal disorders

2.78

1.28

1.0

1.1

9.35

5.49

mg/g

—

Status epilepticus

2.78

1.28

1.4

1.1

7.79

8.21

mg/g

—

Acute lymphadenitis

2.09

1.27

1.1

1.0

5.22

6.95

mg/g

—

Other and unspecified rosacea

2.09

1.27

1.3

1.1

7.02

7.80

mg/g

—

Nail disorders

2.00

1.27

1.0

6.19

7.29

mg/g

0.36

Hypertensive diseases

112

516

1.23

1.26

1.1

8.64

6.91

mg/g

1.36

103

487

Injury of nerves at wrist and hand level

2.41

1.24

1.0

4.65

8.11

mg/g

—

Other disorders of gingiva or/and edentulous alveolar ridge

2.40

1.24

1.0

4.68

8.61

mg/g

—

Ingrowing nail

2.23

1.24

1.0

6.26

7.81

mg/g

—

Congenital malformations of uterus and cervix

2.64

1.21

1.2

1.0

5.44

5.52

mg/g

—

Burns and corrosions confined to eye and internal organs

2.64

1.21

1.0

6.33

6.41

mg/g

—

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

2.64

1.21

1.4

1.0

4.73

5.82

mg/g

—

Dental caries 2 and operation codes

119

784

1.21

1.19

1.1

7.51

6.63

mg/g

0.19

109

745

Dental pulpitis 4, only avohilmo

159

704

1.18

1.17

1.1

6.37

7.19

mg/g

0.70

147

675

Meniscus derangement

338

1.30

1.17

1.0

1.1

6.95

7.64

mg/g

0.41

321

Cystic kidney disease

2.51

1.15

1.2

1.0

14.20

7.10

mg/g

—

Other epidermal thickening

2.50

1.15

1.0

8.23

6.05

mg/g

—

Brain meningioma

2.50

1.15

1.0

1.1

4.74

5.98

mg/g

—

Postprocedural disorders of digestive system, not elsewhere classified

2.51

1.15

1.2

1.0

11.33

7.68

mg/g

—

Hypothyroidism, other/unspecified

120

659

1.20

1.15

1.1

6.32

6.39

mg/g

0.04

113

625

Diseases of external ear

274

1.39

1.14

1.1

6.75

6.96

mg/g

0.09

258

Osteoporosis with pathological fracture (FG)

2.38

1.09

1.0

1.1

5.71

7.89

mg/g

—

Dental pulpitis 1, only avohilmo

158

705

1.17

1.09

1.1

6.38

7.18

mg/g

0.68

146

676

Injuries to the shoulder and upper arm

669

1.22

1.09

1.0

1.1

6.56

7.60

mg/g

0.96

638

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

132

784

1.18

1.08

1.1

7.80

6.85

mg/g

0.67

123

746

Inflammatory diseases of female pelvic organs

533

1.23

1.08

1.1

5.39

5.70

mg/g

0.31

506

Benzodiazepine use

131

788

1.18

1.08

1.1

6.56

7.12

mg/g

0.38

124

749

Atrophic disorders of skin

1.69

1.07

1.1

5.49

7.03

mg/g

0.82

Diseases of pulp and periapical tissues

295

1.36

1.07

1.2

1.1

6.90

7.62

mg/g

0.25

284

Chronic lower respiratory diseases

173

808

1.16

1.06

1.1

7.04

6.97

mg/g

0.04

162

768

Recurring oral aphthae

2.13

1.05

1.0

5.20

6.19

mg/g

—

Other diseases of intestines

156

778

1.17

1.05

1.1

6.39

6.90

mg/g

0.44

144

742

Other hearing loss

111

1.59

1.05

1.1

7.27

9.24

mg/g

0.46

106

Phlebitis and thrombophlebitis (not including DVT)

137

1.53

1.05

1.1

1.0

6.85

7.67

mg/g

0.37

128

Hypertrophy of breast

148

0.54

1.03

1.0

5.34

5.89

mg/g

—

137

Benign neoplasm: Colon, unspecified

1.66

1.02

1.1

10.19

8.55

mg/g

0.17

Acute alcohol intoxication

196

1.43

1.01

1.2

1.1

7.06

7.73

mg/g

0.21

187

Hypothyreosis and Thyroxine purchase for inclusion criteria

121

676

1.18

0.99

1.1

6.30

6.39

mg/g

0.06

114

641

Other bacterial diseases

110

639

1.19

0.99

1.1

9.27

6.79

mg/g

1.79

612

149

0.57

0.98

1.2

1.1

12.81

9.04

mg/g

—

140

Oral leukoplakia and related diseases

2.18

0.98

1.0

9.54

6.73

mg/g

—

Follow-up examination after treatment for malignant neoplasms

0.00

0.97

0.0

1.1

—

8.43

—

Maternal care for known or suspected fetal abnormality and damage

244

1.35

0.97

1.2

1.0

4.65

4.81

mg/g

0.17

223

Disturbance of activity and attention

155

1.47

0.95

1.0

1.1

4.52

5.75

mg/g

1.41

150

Convergent concomitant strabismus

1.77

0.94

1.1

1.0

4.03

7.71

mg/g

—

Ovarian cyst

275

1.26

0.93

1.1

1.0

4.85

5.35

mg/g

0.69

262

Haemorrhage in early pregnancy

342

0.71

0.92

1.1

1.0

4.20

5.32

mg/g

2.92

316

Tongue abnormality

2.15

0.91

1.2

1.0

7.42

6.16

mg/g

—

Other disorders of adrenal gland

2.07

0.89

1.3

1.0

22.55

5.69

mg/g

—

Hyperkinetic disorders

166

1.43

0.89

1.0

4.60

5.57

mg/g

1.06

161

Menorrhagia

240

1.27

0.88

1.0

6.06

5.54

mg/g

0.23

228

Injury of muscle and tendon at lower leg level

1.58

0.87

1.1

9.88

8.24

mg/g

0.40

Malignant neoplasm, wide definition for exclusion

118

597

1.17

0.87

1.1

10.65

6.58

mg/g

1.33

111

563

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

118

597

1.17

0.87

1.1

10.65

6.58

mg/g

1.33

111

563

AV-block

1.72

0.85

1.0

1.1

5.93

8.66

mg/g

1.63

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

113

630

1.17

0.85

1.1

6.63

7.24

mg/g

0.63

107

593

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

1.78

0.84

1.0

3.88

7.45

mg/g

—

LSIL lesion of the cervix uteri, vagina or vulva

162

1.42

0.84

1.0

1.1

4.83

5.00

mg/g

0.11

154

Iridocyclitis

179

1.40

0.83

1.0

1.1

6.13

7.13

mg/g

0.55

169

Skin changes due to chronic exposure to nonionizing radiation

133

0.57

0.83

1.3

1.0

14.08

8.83

mg/g

—

124

Kela-code for severe mental illness

409

0.76

0.80

1.1

5.18

7.15

mg/g

2.21

386

Dental pulpitis 1

153

698

1.14

0.80

1.1

6.62

7.14

mg/g

0.36

142

670

Dental pulpitis 4

153

698

1.14

0.80

1.1

6.62

7.14

mg/g

0.36

142

670

Prepatellar bursitis

0.00

0.79

0.0

1.0

—

10.62

—

Dental caries 2, only avohilmo

115

785

1.16

0.79

1.1

7.68

6.59

mg/g

0.23

105

746

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

117

598

1.16

0.78

1.1

10.66

6.57

mg/g

1.32

110

564

Obesity

695

1.18

0.78

1.0

1.1

6.25

6.51

mg/g

0.21

657

Disorders of the thyroid gland

124

706

1.15

0.76

1.1

6.21

6.53

mg/g

0.26

117

669

Otitis externa

191

1.36

0.76

1.2

1.1

5.97

6.84

mg/g

0.38

181

Obesity and other hyperalimentation

698

1.18

0.75

1.0

1.1

6.25

6.50

mg/g

0.20

660

Other surgical follow-up care

2.09

0.74

1.0

5.30

7.05

mg/g

—

Deviated nasal septum

253

1.30

0.74

1.1

9.30

7.60

mg/g

0.56

237

Diseases of pulp and periapical tissues, including avohilmo

152

698

1.13

0.74

1.1

6.63

7.14

mg/g

0.34

141

670

Benign neoplasm: Long bones of lower limb

2.00

0.72

1.0

4.95

7.63

mg/g

—

Benign neoplasm: Long bones of lower limb

2.00

0.72

1.0

4.95

6.48

mg/g

—

Early complications of trauma

2.00

0.72

1.4

1.0

5.42

8.94

mg/g

—

!Aliquae complicationes praecoces traumatis

2.00

0.72

1.4

1.0

5.42

8.94

mg/g

—

Pustular psoriasis

2.00

0.72

1.0

4.68

6.19

mg/g

—

Biomechanical lesions, not elsewhere classified

2.00

0.72

1.6

1.0

6.94

6.80

mg/g

—

Corneal ulcer

159

0.63

0.72

1.2

1.1

8.34

7.42

mg/g

—

151

Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)

1.55

0.71

1.0

1.1

9.19

8.35

mg/g

0.20

Mental and behavioural disorders due to alcohol

449

1.21

0.71

1.1

6.56

7.52

mg/g

0.67

428

Chronic kidney disease

125

1.43

0.71

1.1

10.26

8.67

mg/g

0.33

119

Any event in cancer register

124

645

1.14

0.70

1.1

10.14

6.42

mg/g

1.25

117

610

Acute alcohol intoxication, ICD10

177

1.36

0.70

1.3

1.1

7.33

7.17

mg/g

0.04

170

Exclusions for E4_PCOS_CONSORTIUM

107

583

1.15

0.70

1.1

6.30

5.72

mg/g

0.47

555

Cardiomyopathy (excluding other)

1.64

0.68

1.1

5.34

8.64

mg/g

—

Inflammatory diseases of prostate (prostatitis)

1.60

0.68

1.0

9.13

9.40

mg/g

0.03

Schizophrenia

156

0.64

0.67

1.0

1.1

4.79

7.16

mg/g

—

150

Medical abortion

416

1.16

0.66

1.0

1.1

5.34

5.73

mg/g

0.33

392

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

1.79

0.66

1.2

1.0

4.44

5.91

mg/g

—

Other and unspecified injuries of wrist and hand

1.79

0.66

1.0

4.96

5.97

mg/g

—

Chronic iridocyclitis

1.79

0.66

1.0

4.56

5.96

mg/g

—

Stomatitis and related lesions

1.61

0.65

1.1

1.0

5.53

8.12

mg/g

—

Injury of eye and orbit

137

1.39

0.64

1.0

1.1

7.84

7.44

mg/g

0.08

132

Other acquired deformities of musculoskeletal system and connective tissue

1.73

0.64

1.4

1.0

9.44

8.66

mg/g

—

Actinic keratosis

123

0.62

0.63

1.3

1.0

14.08

9.07

mg/g

—

115

480

1.19

0.63

1.1

6.98

7.39

mg/g

0.21

458

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

157

0.70

0.63

1.2

1.1

11.70

7.96

mg/g

0.46

146

Hypertrophy of breast in women and men

165

0.67

0.62

1.0

6.57

6.47

mg/g

0.03

154

Polyarthropathies

490

1.16

0.62

1.0

1.1

7.27

6.98

mg/g

0.14

469

Heart failure and bmi 25plus

106

0.65

0.62

1.1

10.40

9.58

mg/g

—

Sleep apnoea

103

613

1.14

0.62

1.1

6.75

7.41

mg/g

0.63

582

Anterior Iridocyclitis

156

1.35

0.60

1.0

6.58

7.19

mg/g

0.25

146

Sudden idiopathic hearing loss

1.57

0.60

1.0

1.1

8.75

9.18

mg/g

—

Open wound of hip and thigh

0.00

0.60

0.0

1.0

—

7.18

—

Long labour

311

0.79

0.59

1.0

1.1

4.85

5.07

mg/g

0.26

290

Complications associated with artificial fertilization

0.00

0.59

0.0

1.0

—

5.42

—

Benign neoplasm: Colon, unspecified

106

1.42

0.57

1.1

10.19

8.96

mg/g

0.13

Parodontitis and operation codes

621

1.14

0.57

1.1

7.38

7.22

mg/g

0.08

592

Renal failure

185

1.28

0.55

1.0

1.1

9.35

8.57

mg/g

0.19

175

Other diseases of anus and rectum

183

0.71

0.55

1.0

9.44

7.67

mg/g

0.31

172

Acute pharyngitis

176

1.30

0.54

1.1

5.39

6.21

mg/g

0.59

170

Gastro-oesophageal reflux disease

571

1.15

0.53

1.1

6.25

7.23

mg/g

0.72

539

Alcohol use disorder, ICD-based

358

1.20

0.53

1.1

6.88

7.40

mg/g

0.23

338

Mental and behavioural disorders due to alcohol, excluding acute intoxication

386

1.19

0.52

1.1

6.65

7.63

mg/g

0.55

366

Malignant neoplasm of digestive organs

144

0.68

0.52

1.3

1.1

13.37

8.71

mg/g

—

136

All-cause Heart Failure

196

0.77

0.52

1.1

7.92

9.10

mg/g

0.39

184

Caught, crushed, jammed or pinched in or between objects

1.50

0.51

1.0

6.76

6.94

mg/g

—

HSIL lesion of the cervix uteri, vagina or vulva

259

0.77

0.51

1.0

1.1

5.06

5.09

mg/g

0.02

242

Parodontitis

638

1.12

0.49

1.1

7.56

7.28

mg/g

0.14

610

Parodontitis or operation codes

638

1.12

0.49

1.1

7.56

7.28

mg/g

0.14

610

Other heart diseases, wide

132

743

1.10

0.48

1.0

1.1

6.50

7.03

mg/g

0.39

124

708

Kidney transplant status

1.52

0.48

1.1

1.0

8.95

9.35

mg/g

—

Fitting and adjustment of other devices

133

0.70

0.47

1.0

1.1

7.63

8.21

mg/g

—

124

Oxicams

0.72

0.47

1.0

1.1

7.41

6.35

mg/g

0.47

Cellulitis

164

1.28

0.46

1.1

1.0

10.07

7.17

mg/g

0.61

156

Glucagon-like peptide-1 (GLP-1) analogues

255

0.81

0.46

1.0

1.1

10.18

8.21

mg/g

0.39

238

Other and unspecified anaemias

203

1.24

0.44

1.2

1.1

8.67

8.23

mg/g

0.06

191

Diseases of the skin and subcutaneous tissue

144

661

1.09

0.44

1.1

6.96

6.85

mg/g

0.06

136

624

Acute renal failure

1.40

0.44

1.0

1.1

11.78

9.00

mg/g

0.42

Monoamine oxidase A inhibitors

1.45

0.44

1.0

6.27

9.04

mg/g

—

Other anaemias

203

1.24

0.44

1.2

1.1

8.67

8.23

mg/g

0.06

191

Iron deficiency anaemia secondary to blood loss (chronic)

1.41

0.43

1.2

1.1

5.35

7.72

mg/g

1.05

Ankylosing spondylitis, strict definition

1.61

0.43

1.0

5.10

9.78

mg/g

—

Complications of surgical and medical care, not elsewhere classified

115

751

1.10

0.42

1.1

5.99

6.97

mg/g

1.51

109

712

Acute and subacute iridocyclitis

149

1.28

0.41

1.0

6.80

7.36

mg/g

0.21

139

Dependent personality disorder

0.00

0.41

0.0

1.0

—

6.57

—

Heart failure,strict

197

0.81

0.41

1.1

7.96

9.00

mg/g

0.35

186

Fentanyl

1.51

0.41

1.0

12.44

9.30

mg/g

—

Infective bursitis

0.00

0.41

0.0

1.0

—

9.85

—

Other secondary coxarthrosis

0.00

0.41

0.0

1.1

—

6.36

—

Ovarian hyperstimulation (induction)

0.00

0.41

0.0

1.0

—

5.07

—

Schizotypal disorder

0.00

0.41

0.0

1.0

—

6.52

—

Short Achilles tendon (acquired)

0.00

0.41

0.0

1.0

—

6.23

—

Disorder of external ear, unspecified

0.00

0.41

0.0

1.0

—

6.65

—

Benign neoplasm of thyroid gland

0.00

0.41

0.0

1.1

—

6.56

—

Malignant neoplasm

106

571

1.10

0.41

1.1

11.03

6.73

mg/g

1.23

538

Other benign neoplasms of uterus

0.00

0.40

0.0

1.1

—

7.37

—

Other benign neoplasms of uterus

0.00

0.40

0.0

1.0

—

7.49

—

Leiomyoma of uterus

359

1.12

0.40

1.1

8.55

5.86

mg/g

1.43

338

Crohn disease (strict definition, all UC cases excluded)

1.43

0.39

1.0

4.35

7.00

mg/g

—

Other noninfective disorders of lymphatic vessels and lymph nodes

0.00

0.39

0.0

1.1

—

6.05

—

Benign neoplasm of other and unspecified female genital organs

0.00

0.39

0.0

1.1

—

6.18

—

Alcohol dependence

205

1.22

0.39

1.1

6.02

8.48

mg/g

2.65

192

Hypertrophic scar

1.39

0.38

1.0

6.16

6.17

mg/g

—

Hordeolum and other deep inflammation of eyelid

1.39

0.38

1.2

1.0

6.49

7.15

mg/g

—

Nontoxic single thyroid nodule

1.39

0.38

1.0

1.1

10.30

7.22

mg/g

—

Chronic periodontitis, including avohilmo

639

1.10

0.38

1.1

7.64

7.27

mg/g

0.19

611

Disorders of tooth development and eruption

1.35

0.38

1.0

1.1

7.28

6.76

mg/g

—

Other abnormal uterine and vaginal bleeding

153

0.79

0.37

1.0

5.80

5.49

mg/g

0.16

146

Acute tubulo-interstitial nephritis

498

1.12

0.37

1.1

5.85

6.68

mg/g

1.09

472

HSIL lesion of the cervix uteri

246

0.81

0.36

1.0

1.1

5.06

5.05

mg/g

0.01

231

Abnormal findings on antenatal screening of mother

124

0.73

0.35

1.0

4.06

4.63

mg/g

—

119

507

1.11

0.33

1.1

6.98

7.34

mg/g

0.18

482

Labour and delivery complicated by fetal stress [distress]

291

0.87

0.33

1.1

5.23

5.13

mg/g

0.05

272

Heart failure, strict

198

0.84

0.32

1.1

7.79

9.05

mg/g

0.46

186

Nontoxic goitre/thyroid nodule

197

0.81

0.31

1.0

1.1

8.63

7.22

mg/g

0.24

184

Alcohol use disorder, Swedish definition

450

1.11

0.30

1.1

7.09

7.42

mg/g

0.14

428

Hernia

107

673

1.08

0.30

1.1

8.32

7.45

mg/g

0.36

639

Gonarthrosis [arthrosis of knee](FG)

352

1.10

0.30

1.0

1.1

7.00

7.83

mg/g

0.47

333

Glucosamine medication

190

0.84

0.28

1.1

7.19

9.12

mg/g

1.10

177

Benign neoplasm of breast

1.25

0.27

1.3

1.0

4.85

5.34

mg/g

—

Abnormalities of forces of labour

116

0.78

0.27

1.0

1.1

4.86

5.50

mg/g

—

107

Diseases of oesophagus, stomach and duodenum

131

748

1.06

0.26

1.1

7.12

6.82

mg/g

0.16

124

710

Leiomyoma of uterus

297

1.10

0.26

1.0

8.06

5.55

mg/g

1.09

277

Polycystic ovarian syndrome, broad definition

160

0.81

0.26

1.0

1.1

4.67

4.75

mg/g

0.05

155

Diseases of appendix

791

1.07

0.25

1.1

6.89

7.00

mg/g

0.05

751

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

1.17

0.24

1.0

1.1

4.96

7.50

mg/g

—

Asthma/COPD (KELA code 203)

121

804

1.06

0.24

1.1

6.86

6.97

mg/g

0.05

113

765

Foreign body in alimentary tract

1.28

0.23

1.0

3.50

7.84

mg/g

—

Cutaneous abscess, furuncle and carbuncle

253

0.87

0.22

1.0

1.1

7.23

6.54

mg/g

0.30

241

Appendicitis, broad definition

789

1.07

0.22

1.1

6.87

7.01

mg/g

0.06

749

Hypertrophic disorders of skin

1.22

0.22

1.0

6.16

5.97

mg/g

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

106

763

0.94

0.21

1.1

6.91

6.72

mg/g

0.11

101

722

Aplastic and other anaemias

226

1.13

0.21

1.3

1.1

8.51

7.89

mg/g

0.08

213

Other congenital malformations of heart

0.00

0.21

0.0

1.0

—

7.83

—

Other congenital malformations of limb(s)

0.00

0.21

0.0

1.0

—

5.33

—

Other diseases caused by chlamydiae

0.00

0.21

0.0

1.0

—

6.15

—

HSIL lesion of the vagina

0.00

0.21

0.0

1.0

—

6.32

—

Donors of organs and tissues

0.00

0.21

0.0

1.0

—

5.69

—

Carcinoma in situ of other and unspecified genital organs

0.00

0.21

0.0

1.0

—

4.97

—

Carcinoma in situ of other and unspecified genital organs

0.00

0.21

0.0

1.0

—

5.45

—

Adhesive middle ear disease

0.00

0.21

0.0

1.0

—

5.61

—

conjunctival degenerations and deposits

0.00

0.21

0.0

1.0

—

6.83

—

Malignant neoplasm of other connective and soft tissue

0.00

0.21

0.0

1.0

—

5.88

—

Anaemia in chronic diseases classified elsewhere

0.00

0.21

0.0

1.0

—

6.34

—

Benign neoplasm: Duodenum

0.00

0.21

0.0

1.0

—

6.56

—

Other and unspecified acute skin changes due to ultraviolet radiation

0.00

0.21

0.0

1.0

—

6.80

—

Hyperaldosteronism

0.00

0.21

0.0

1.0

—

6.84

—

Supernumerary teeth EXCLUDE clefts and syndromes, including avohilmo

0.00

0.21

0.0

1.1

—

7.71

—

Unspecified maternal hypertension

0.00

0.21

0.0

1.0

—

5.94

—

Occupant of special all-terrain or other motor vehicle designed primarily for off-road use, injured in transport accident

0.00

0.21

0.0

1.0

—

9.32

—

Patellar tendinitis

0.00

0.21

0.0

1.0

—

9.55

—

Other misadventures during surgical and medical care

0.00

0.21

0.0

1.0

—

6.79

—

Other conjunctival vascular disorders and cysts

0.00

0.21

0.0

1.0

—

6.79

—

Benign neoplasm: Duodenum

0.00

0.21

0.0

1.0

—

7.11

—

Benign neoplasm: Tongue

0.00

0.21

0.0

1.0

—

6.49

—

Problems related to social environment

0.00

0.21

0.0

1.0

—

9.12

—

Follicular lymphoma, hilmo

0.00

0.21

0.0

1.0

—

7.15

—

Primary angle-closure glaucoma

0.00

0.21

0.0

1.0

—

6.59

—

Complex cardiac defects

0.00

0.21

0.0

1.0

—

7.25

—

Poor fetal growth

177

0.85

0.21

1.2

1.1

4.49

4.77

mg/g

0.28

171

Anxious personality disorder

0.00

0.21

0.0

1.0

—

5.55

—

Assault by unspecified means

0.00

0.21

0.0

1.0

—

6.74

—

Toxic effect of alcohol

0.00

0.21

0.0

1.0

—

6.63

—

Oral leukoplakia, including avohilmo

0.00

0.21

0.0

1.0

—

6.59

—

Dental caries 3 and operation codes

100

544

0.94

0.20

1.1

6.05

7.13

mg/g

1.12

522

Congenital malformations of cardiac chambers and connections

0.00

0.20

0.0

1.0

—

6.72

—

Other congenital malformations of male genital organs

0.00

0.20

0.0

1.1

—

6.51

—

Intussusception

0.00

0.20

0.0

1.1

—

5.93

—

0.00

0.20

0.0

1.0

—

5.18

—

Benign neoplasm: Tongue

0.00

0.20

0.0

1.0

—

6.52

—

Burn and corrosion of trunk

0.00

0.20

0.0

1.0

—

6.14

—

Status post-ami

0.00

0.20

0.0

1.1

—

11.19

—

Other disorders of ear

603

1.06

0.20

1.1

7.52

7.25

mg/g

0.14

575

Opening and dilatation of root channel of tooth

1.23

0.20

1.0

4.59

7.80

mg/g

—

Parodontitis or/and operation codes

406

1.07

0.19

1.1

6.59

6.33

mg/g

0.15

382

Hallux valgus (acquired)

173

0.88

0.19

1.0

1.1

5.70

6.94

mg/g

0.83

162

Crohn disease (strict definition, require KELA, min 2 HDR)

1.13

0.18

1.0

4.35

7.72

mg/g

—

Crohn disease (strict definition, require KELA)

1.13

0.18

1.0

4.35

7.72

mg/g

—

Cholelithiasis

559

0.94

0.18

1.1

7.59

7.05

mg/g

0.23

524

Dysplasia of cervi uteri

246

1.10

0.18

1.0

5.04

5.15

mg/g

0.08

234

Dental caries 3, only avohilmo

485

0.95

0.16

1.1

6.68

7.03

mg/g

0.17

466

Infections of the skin and subcutaneous tissue

629

1.06

0.16

1.2

1.1

8.55

6.86

mg/g

0.64

594

Acute appendicitis

771

1.05

0.16

1.1

6.92

7.00

mg/g

0.03

732

Renal tubulo-interstitial diseases

679

1.05

0.15

1.1

6.73

6.54

mg/g

0.14

647

Hypothyroidism, strict autoimmune, 3 medication purchases required

631

1.05

0.15

1.1

6.10

6.26

mg/g

0.11

597

Cholelithiasis, broad definition with cholecystitis

570

0.95

0.15

1.1

7.48

7.05

mg/g

0.18

534

Other disorders of breast

102

1.18

0.15

1.0

1.1

4.12

5.70

mg/g

1.75

Hernia of abdominal wall

347

0.92

0.14

1.1

9.54

7.40

mg/g

0.34

331

Seborrhoeic keratosis

0.82

0.13

1.3

1.1

14.25

8.37

mg/g

—

L02BA Anti-estrogens

0.82

0.13

1.0

1.1

5.40

6.22

mg/g

—

Other noninflammatory disorders of uterus, except cervix

109

0.88

0.13

1.0

10.36

5.99

mg/g

0.73

103

Dental caries 3

475

0.96

0.12

1.1

6.81

6.91

mg/g

0.05

456

Combinations of oral blood glucose lowering drugs

142

1.13

0.12

1.0

1.1

8.62

8.20

mg/g

0.12

130

Myocardial infarction, without ST-elevation

131

1.13

0.12

1.3

1.1

8.89

9.19

mg/g

0.06

124

Early lumbar disc prolapse operation

127

0.87

0.12

1.0

1.1

5.41

6.55

mg/g

0.50

122

Pregnancy examination and test

164

0.91

0.12

1.0

6.18

5.27

mg/g

0.24

152

Redundant prepuce, phimosis and paraphimosis

199

0.90

0.12

1.1

9.14

9.76

mg/g

0.12

190

Dental caries 1 and operation codes

497

0.96

0.12

1.1

6.07

7.37

mg/g

1.28

479

Endometriosis

263

1.06

0.12

1.1

1.0

7.17

5.41

mg/g

0.93

251

Primary open-angle glaucoma

111

1.14

0.12

1.2

1.1

9.14

8.83

mg/g

0.07

104

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

168

0.89

0.11

1.0

1.1

7.18

7.20

mg/g

0.01

155

Sleep apnoea, including avohilmo

107

672

1.03

0.10

1.1

6.82

7.52

mg/g

0.54

100

636

Dental caries, including avohilmo

420

1.03

0.09

1.1

6.50

7.19

mg/g

0.42

405

Dental caries 1

420

1.03

0.08

1.1

6.50

7.19

mg/g

0.42

405

Carbimazole or st.post thyroidectomy, condition for graves disease

165

1.09

0.08

1.2

1.0

7.87

6.56

mg/g

0.29

156

Dental caries 1, only avohilmo

431

1.03

0.08

1.1

6.46

7.24

mg/g

0.50

416

Antepartum haemorrhage, not elsewhere classified

127

1.10

0.07

1.0

4.31

5.10

mg/g

0.97

119

Carpal tunnel syndrome

442

1.04

0.07

1.0

1.1

7.74

7.19

mg/g

0.22

422

Benign mammary dysplasia

1.03

0.07

1.0

1.1

5.19

6.86

mg/g

—

Other abnormal products of conception

320

1.04

0.07

1.1

4.81

5.08

mg/g

0.33

301

Other complications of labour and delivery, not elsewhere classified

187

0.93

0.07

1.1

4.98

4.54

mg/g

0.27

181

malignant neoplasm of female genital organs, excluding all cancers (controls excluding all cancers)

0.84

0.07

1.0

1.1

11.82

7.02

mg/g

—

Seropositive rheumatoid arthritis, strict definition

1.02

0.07

1.0

5.32

8.29

mg/g

—

Spondylolisthesis/Spondylolysis

0.85

0.06

1.0

1.1

6.58

6.84

mg/g

—

Postpartum haemorrhage due to anatomy

128

1.09

0.06

1.0

1.1

3.81

4.50

mg/g

1.27

123

Gestational [pregnancy-induced] hypertension

353

1.05

0.06

1.0

4.88

5.19

mg/g

0.35

329

Colorectal cancer, excluding all cancers (controls excluding all cancers)

0.89

0.06

1.1

6.97

8.66

mg/g

—

Maternal care for known or suspected abnormality of pelvic organs

280

0.96

0.06

1.1

1.0

5.15

5.36

mg/g

0.12

258

Ectopic pregnancy

192

0.94

0.05

1.1

6.11

5.67

mg/g

0.21

181

Gonarthrosis,primary

410

1.03

0.05

1.0

1.1

7.16

8.11

mg/g

0.59

385

Foreign body on external eye

130

0.92

0.04

1.0

8.00

8.15

mg/g

0.02

125

Nontoxic multinodular goitre

108

0.93

0.03

1.0

1.1

8.34

6.98

mg/g

—

Artrosis, including avohilmo

536

1.01

0.02

1.0

1.1

6.42

7.64

mg/g

1.03

512

Heart failure and antihypertensive medication

1.06

0.02

1.1

5.96

9.31

mg/g

1.97

All dysplastic lesions of the cervix uteri, vagina or vulva

387

0.98

0.02

1.0

1.1

5.24

5.29

mg/g

0.04

360

Disorders of gallbladder, biliary tract and pancreas

101

644

1.01

0.02

1.1

7.57

7.03

mg/g

0.30

607

Disorders of breast

471

0.98

0.01

1.0

1.1

4.71

6.06

mg/g

3.21

444

In situ neoplasms

223

1.03

0.00

1.2

1.0

8.88

6.64

mg/g

0.41

210

Psoriasis vulgaris

133

0.98

0.00

1.1

9.96

7.03

mg/g

0.58

124

All dysplastic lesions of the cervix uteri

356

1.01

0.00

1.0

5.02

5.07

mg/g

0.04

331

Dental pulpitis 2

382

1.01

0.00

1.1

6.57

7.32

mg/g

0.43

369

Dental pulpitis 2, only avohilmo

387

1.00

0.00

1.1

6.53

7.31

mg/g

0.45

373

In situ neoplasms

241

1.00

0.00

1.2

1.0

8.88

6.15

mg/g

0.53

226

Injuries to the elbow and forearm

683

1.01

0.00

1.1

6.90

6.98

mg/g

0.03

648

Arthrosis

395

1.00

0.00

1.0

1.1

7.15

7.54

mg/g

0.17

377

Other (seronegative) rheumatoid arthritis, wide

109

1.01

0.00

1.0

1.1

6.11

7.63

mg/g

1.01

100

Benign neoplasm of other and unspecified intrathoracic organs

0.00

0.0

1.0

—

6.42

—

Family history of other conditions

0.00

0.0

1.0

—

5.80

—

Other bursitis of hip

0.00

0.0

1.0

—

7.45

—

Assault by other specified means

0.00

0.0

1.0

—

6.49

—

Mesial bite

0.00

0.0

1.2

—

4.32

—

Diseases caused by chlamydiae

0.00

0.0

1.0

—

5.87

—

Malignant neoplasm of other and unspecified female genital organs

0.00

0.0

1.0

—

5.62

—

Guttate psoriasis

0.00

0.0

1.0

—

6.57

—

Defects in the complement system

0.00

0.0

1.0

—

4.66

—

Combined immunodeficiencies

0.00

0.0

1.0

—

6.38

—

Moderate visual impairment, binocular

0.00

0.0

1.0

—

4.36

—

Other injuries of lower limb, level unspecified

0.00

0.0

1.0

—

5.92

—

Benign neoplasm: Oesophagus

0.00

0.0

1.0

—

7.70

—

Varus deformity, not elsewhere classified

0.00

0.0

1.0

—

6.31

—

Carcinoma in situ of cervix uteri, exocervix

0.00

0.0

1.0

—

5.73

—

Other benign neoplasm of uterus: Other parts/unspecified

0.00

0.0

1.1

—

7.20

—

Poisoning by medicine, drug-induced

0.00

0.0

1.0

—

6.69

—

Benign neoplasm: Tonsil

0.00

0.0

1.0

—

6.52

—

Protein-energy malnutrition of moderate and mild degree

0.00

0.0

1.0

—

3.89

—

Benign neoplasm: Nasopharynx

0.00

0.0

1.0

—

6.02

—

Congenital malformations of posterior segment of eye

0.00

0.0

1.0

—

13.03

—

Benign neoplasm: Nasopharynx

0.00

0.0

1.0

—

5.86

—

Open wound of thorax

0.00

0.0

1.0

—

6.40

—

Malignant neoplasm of bone and articular cartilage, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.0

—

6.65

—

Deep bite that required surgery

0.00

0.0

1.0

—

7.05

—

Congenital malformations of oesophagus

0.00

0.0

1.0

—

10.11

—

Lymphangioma, anys site

0.00

0.0

1.0

—

6.20

—

Congenital malformation of biliary tract

0.00

0.0

1.0

—

10.74

—

Benign neoplasm: Vagina

0.00

0.0

1.0

—

5.29

—

Other disturbances of cerebral status of newborn

0.00

0.0

1.0

—

2.56

—

Cleft lip and palate

0.00

0.0

1.0

—

5.82

—

Benign neoplasm: Tonsil

0.00

0.0

1.0

—

7.20

—

Melanocytic naevi of lip

0.00

0.0

1.0

—

6.29

—

Disorders of globe

0.00

0.0

1.0

—

6.54

—

Other specified transport accidents

0.00

0.0

1.0

—

5.46

—

Benign neoplasm: Other/unspecified site

0.00

0.0

1.0

—

6.03

—

Intentional self-harm by jumping from a high place

0.00

0.0

1.0

—

4.95

—

Other sex chromosome abnormalities, male phenotype, not elsewhere classified

0.00

0.0

1.0

—

5.44

—

Prolapse and hernia of ovary and fallopian tube

0.00

0.0

1.1

—

8.37

—

Congenital malformations of spine and bony thorax

0.00

0.0

1.0

—

4.79

—

Abscess of external ear

0.00

0.0

1.0

—

6.45

—

Moderate mental retardation

0.00

0.0

1.0

—

4.16

—

Kyphosis

0.00

0.0

1.0

—

7.28

—

Carcinoma in situ of breast, other/unspecified

0.00

0.0

1.0

—

5.70

—

Benign neoplasm: Bronchus and lung

0.00

0.0

1.0

—

7.59

—

Tularaemia

0.00

0.0

1.0

—

8.23

—

Fall involving bed

0.00

0.0

1.0

—

5.24

—

Traumatic ischaemia of muscle

0.00

0.0

1.0

—

6.23

—

Retinoschisis and retinal cysts

0.00

0.0

1.0

—

5.43

—

Other benign neoplasm of uterus: Other parts/unspecified

0.00

0.0

1.0

—

8.12

—

Benign neoplasm: Vagina

0.00

0.0

1.0

—

5.35

—

Carcinoma in situ of cervix uteri, exocervix

0.00

0.0

1.0

—

6.41

—

Benign neoplasm: Uterine tubes and ligaments

0.00

0.0

1.0

—

7.32

—

Whooping cough

0.00

0.0

1.0

—

5.13

—

Arthropathy in Crohn disease

0.00

0.0

1.0

—

6.37

—

Chronic mastoiditis

0.00

0.0

1.0

—

6.09

—

Transient synovitis

0.00

0.0

1.0

—

11.45

—

Benign neoplasm: Other/unspecified site

0.00

0.0

1.2

—

5.89

—

Benign neoplasm of other and unspecified intrathoracic organs

0.00

0.0

1.0

—

6.67

—

Discitis, unspecified

0.00

0.0

1.0

—

6.58

—

Lymphangioma, anys site

0.00

0.0

1.0

—

6.17

—

Benign neoplasm: Bone and articular cartilage, unspecified

0.00

0.0

1.0

—

5.88

—

Postdysenteric arthropathy

0.00

0.0

1.0

—

6.64

—

Need for immunization against single bacterial diseases

0.00

0.0

1.0

—

3.33

—

Previous suicide attempt

0.00

0.0

1.0

—

5.66

—

0.00

0.0

1.0

—

5.98

—

Family history of mental and behavioural disorders

0.00

0.0

1.0

—

11.12

—

Carcinoma in situ of vulva

0.00

0.0

1.0

—

4.98

—

Sequelae of other accidents

0.00

0.0

1.0

—

6.34

—

Other factor of the environment

0.00

0.0

1.0

—

5.85

—

Foreign body or object entering through skin

0.96

0.00

1.0

7.15

9.13

mg/g

—

Exposure to unspecified smoke, fire and flames

0.00

0.0

1.0

—

6.92

—

Assault by blunt object

0.00

0.0

1.0

—

6.11

—

Ankylosis of joint

0.00

0.0

1.0

—

6.46

—

Cleft lip and cleft lip and palate

0.00

0.0

1.0

—

5.14

—

Other bursal cyst

0.00

0.0

1.0

—

7.68

—

Other injuries of upper limb, level unspecified

0.00

0.0

1.0

—

6.17

—

Other and unspecified injuries of neck

0.00

0.0

1.0

—

5.73

—

Benign neoplasm: Bronchus and lung

0.00

0.0

1.0

—

7.33

—

Open wound of neck

0.00

0.0

1.0

—

6.48

—

Other adrenocortical overactivity

0.00

0.0

1.0

—

5.58

—

Other and unspecified injuries of thorax

0.00

0.0

1.0

—

5.33

—

Mesothelioma, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.0

—

7.62

—

Benign neoplasm: Vulva

0.00

0.0

1.1

—

5.63

—

Hypothermia

0.00

0.0

1.0

—

7.66

—

Migraine without aura, drug-induced

0.00

0.0

1.0

—

6.66

—

Diffuse brain injury

0.00

0.0

1.0

—

8.15

—

Other nonscarring hair loss

0.00

0.0

1.0

—

6.37

—

Congenital malformations of ear causing impairment of hearing

0.00

0.0

1.0

—

4.27

—

Portal vein thrombosis

0.00

0.0

1.0

—

6.53

—

Flatulence and related conditions

0.00

0.0

1.0

—

7.36

—

Lupus erythematosus

0.00

0.0

1.0

—

5.72

—

Congenital malformations of trachea and bronchus

0.00

0.0

1.0

—

6.15

—

Other abnormal findings in urine

0.00

0.0

1.0

—

6.21

—

Other congenital malformations of urinary system

0.00

0.0

1.0

—

4.44

—

Renal agenesis and other reduction defects of kidney

0.00

0.0

1.0

—

8.97

—

Other congenital malformations of skull and face bones

0.00

0.0

1.0

—

4.60

—

Chronic respiratory disease originating in the perinatal period

0.00

0.0

1.2

—

2.56

—

Burns and corrosions of multiple body regions

0.00

0.0

1.0

—

6.94

—

Congenital malformations of gallbladder, bile ducts and liver

0.00

0.0

1.0

—

9.59

—

Fetus and newborn affected by complications of placenta, cord and membranes

0.00

0.0

1.1

—

4.56

—

Fetus and newborn affected by noxious influences transmitted via placenta or breast milk

0.00

0.0

1.0

—

7.32

—

Other immunodeficiencies

0.00

0.0

1.0

—

4.44

—

Neuroendocrine tumor and carcinoma of small intestine, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.0

—

7.33

—

Female infertility, uterine origin

0.00

0.0

1.0

—

6.90

—

Synovial hypertrophy, not elsewhere classified

0.00

0.0

1.0

—

7.50

—

Other bursitis, not elsewhere classified

0.00

0.0

1.0

—

7.22

—

Measles

0.00

0.0

1.0

—

6.27

—

Unequal limb length (acquired)

0.00

0.0

1.0

—

6.99

—

Infliximab

0.00

0.0

1.0

—

5.73

—

Contracture of joint

0.00

0.0

1.0

—

7.54

—

Pyogenic granuloma

0.00

0.0

1.0

—

5.90

—

Calcific tendinitis

0.00

0.0

1.0

—

6.21

—

Hypertrophy of (infrapatellar) fat pad

0.00

0.0

1.0

—

7.57

—

Endometriosis of fallopian tube

0.00

0.0

1.0

—

6.57

—

Other specified/unspecified nutritional deficiencies

0.00

0.0

1.0

—

6.22

—

Universal erythroderma, KELA reimbursement

0.00

0.0

1.0

—

6.14

—

Benign neoplasm: Vulva

0.00

0.0

1.0

—

6.24

—

Oral leukoplakia

0.00

0.0

1.0

—

7.94

—

Maxillary prognathism

0.00

0.0

1.0

—

3.82

—

Mandibular prognathia AND surgery (LeFortI or BSSRO)

0.00

0.0

1.0

—

5.84

—

Oral lichen ruber planus

0.00

0.0

1.0

—

6.54

—

Gastrojejunal ulcer

0.00

0.0

1.0

—

6.46

—

ILD medications: pirfenidone

0.00

0.0

1.0

—

8.60

—

Primary open-angle glaucoma, strict

0.94

0.00

1.1

10.19

8.34

mg/g

—

Hypertension, Pulmonary Arterial

0.00

0.0

1.0

—

4.75

—

Hyphaema and other vascular disorders of iris and ciliary body

0.00

0.0

1.0

—

6.79

—

HSIL lesion of the vulva

0.00

0.0

1.0

—

5.16

—

Disorders of iron metabolism

0.00

0.0

1.0

—

5.97

—

Hypothyroidism due to medicaments and other exogenous substances

0.00

0.0

1.0

—

7.24

—

Hypertrophy of tongue papillae

0.00

0.0

1.0

—

6.15

—

Lifestyle-related condition

0.00

0.0

1.0

—

5.84

—

Benign neoplasm: Oesophagus

0.00

0.0

1.0

—

7.62

—

Benign neoplasm: Bone and articular cartilage, unspecified

0.00

0.0

1.0

—

6.80

—

Melanocytic naevi of lip

0.00

0.0

1.0

—

6.67

—

Secondary malignant neoplasm of other and unspecified sites

0.00

0.0

1.0

—

6.75

—

Malignant neoplasm of vulva, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.0

—

4.90

—

Endometroid carcinoma of ovary

0.00

0.0

1.0

—

5.71

—

Malignant neoplasm of rectosigmoid junction

0.00

0.0

1.0

—

7.21

—

Malignant neoplasm of other and ill-defined digestive organs, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.0

—

6.52

—

Neuroendocrine tumor and carcinoma of pancreas, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.0

—

6.52

—

Malignant neoplasm of bone and articular cartilage of other and unspecified sites, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.0

—

6.26

—

Hepatocellular carcinoma

0.00

0.0

1.0

—

8.18

—

Malignant neoplasm of oesophagus

0.00

0.0

1.0

—

7.79

—

Paranoid personality disorder

0.00

0.0

1.0

—

6.85

—

Inhalation and ingestion of food causing obstruction of respiratory tract

0.00

0.0

1.0

—

6.15

—

Cardiomyopathy, Hypertrophic obstructive

0.00

0.0

1.0

—

6.85

—

Amputation of ankle bones

0.00

0.0

1.0

—

7.11

—

Left hemicolectomy

0.00

-0.00

0.0

1.0

—

6.79

—

Injury of cranial nerves

0.00

-0.00

0.0

1.0

—

6.60

—

Contact with other and unspecified heat and hot substances

0.00

-0.00

0.0

1.0

—

5.79

—

Hand

0.00

-0.00

0.0

1.0

—

6.32

—

Mature T/NK-cell lymphomas, hilmo, excluding all cancers

0.00

-0.00

0.0

1.0

—

7.59

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Albumin in CSF/Albumin in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS